Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway
Open Access
Abstract
Evodiamine is one of the main components isolated from Evodia rutaecarpa, and it has been reported to exert inhibitory effects on cancers by anti-proliferative and apoptosis-inducing activities. Although the anti-cancer activity of evodiamine has been identified, the precise mechanisms of this action remain obscure. While previous studies indicated that evodiamine exerts anti-tumor effects through inhibiting β-catenin activity, and WW domain-containing oxidoreductase (WWOX) regulates β-catenin accumulation in cytoplasm, the effects of evodiamine on the expression of WWOX are still unknown. In this study, we provide evidence that evodiamine dose- and time-dependently inhibits both Mus musculus and Homo sapiens hepatocellular carcinoma (HCC) cells, as well as Hepa1-6 and HepG2 cell proliferation. We further tested the therapeutic effects of evodiamine in Hepa1-6 hepatoma-bearing mice, and we found that treatment of evodiamine by oral gavage significantly decreased the tumor size of the mice. Moreover, the expressions of WWOX were dose-dependently increased in HCC cell lines as well as in Hepa1-6 hepatoma-bearing mice after the treatment with evodiamine. Knockdown of WWOX in HepG2 and Hepa1-6 cells diminished the effects of evodiamine on the inhibitory effect of cancer cell growth, indicating that evodiamine induced anti-cancer activity through a WWOX-dependent pathway. As such, evodiamine activated WWOX to exert an anti-HCC activity, and might be a potential therapeutic or preventive candidate for HCC treatment.Keywords
This publication has 23 references indexed in Scilit:
- Social overcrowding as a chronic stress model that increases adiposity in micePsychoneuroendocrinology, 2015
- WWOX: A fragile tumor suppressorExperimental Biology and Medicine, 2014
- Denbinobin upregulates miR-146a expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytesJournal of Molecular Medicine, 2014
- SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cellTumor Biology, 2014
- Growth inhibition and induction of apoptosis in SGC-7901 human gastric cancer cells by evodiamineMolecular Medicine Reports, 2014
- The expression and significance of WWOX and β‐catenin in hepatocellular carcinomaAPMIS, 2012
- Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the badSeminars in Cancer Biology, 2011
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- INDUCTION OF MITOTIC ARREST AND APOPTOSIS IN HUMAN PROSTATE CANCER PC-3 CELLS BY EVODIAMINEJournal of Urology, 2005
- Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaPInternational Journal of Cancer, 2004